Catherine C Park Selected Research

Integrin beta1

7/2010	HER2 signaling pathway activation and response of breast cancer cells to HER2-targeting agents is dependent strongly on the 3D microenvironment.
11/2009	beta1 integrin targeting to enhance radiation therapy.
6/2008	Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts.
2/2006	Beta1 integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Catherine C Park Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2006
14	Neoplasms (Cancer) 01/2022 - 02/2006
3	Neoplasm Metastasis (Metastasis) 10/2017 - 11/2007
2	Glioblastoma (Glioblastoma Multiforme) 10/2017 - 05/2013
2	Hypoxia (Hypoxemia) 10/2017 - 05/2013
1	Residual Neoplasm 01/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Carcinogenesis 05/2015
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2013

Drug/Important Bio-Agent (IBA)

9	IntegrinsIBA 10/2017 - 02/2006
5	Laminin (Merosin)IBA 06/2013 - 02/2006
4	Integrin beta1IBA 07/2010 - 02/2006
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2009
2	Phosphotransferases (Kinase)IBA 01/2018 - 05/2015
2	Bevacizumab (Avastin)FDA Link 10/2017 - 05/2013
2	Lapatinib (GW572016)FDA Link 08/2011 - 07/2010
2	Trastuzumab (Herceptin)FDA Link 08/2011 - 07/2010
2	AntibodiesIBA 07/2010 - 06/2008
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	DNA-Activated Protein KinaseIBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	LigandsIBA 10/2017
1	Chemotactic FactorsIBA 10/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017
1	Neutralizing AntibodiesIBA 10/2017
1	Interleukin-4 (Interleukin 4)IBA 05/2015
1	pexidartinibIBA 05/2015
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 05/2015
1	CytokinesIBA 05/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2015
1	Interleukin-13IBA 05/2015
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 05/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2013
1	Phenobarbital (Luminal)FDA Link 01/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2013
1	ErbB Receptors (EGF Receptor)IBA 08/2011
1	Fibronectins (Fibronectin)IBA 07/2010
1	Humanized Monoclonal AntibodiesIBA 07/2010
1	Integrin alpha5beta1IBA 07/2010
1	pertuzumabIBA 07/2010

Therapy/Procedure

13	Therapeutics 01/2021 - 02/2006
8	Radiotherapy 01/2018 - 11/2007
3	Drug Therapy (Chemotherapy) 01/2021 - 11/2007
2	Neoadjuvant Therapy 01/2018 - 01/2013
2	Segmental Mastectomy (Lumpectomy) 02/2014 - 01/2009
1	Mastectomy (Mammectomy) 02/2014
1	Brachytherapy 09/2013
1	Drug Tapering 05/2013